Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease - PubMed (original) (raw)
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease
S Sakaguchi et al. J Exp Med. 1985.
Abstract
Organ-specific autoimmune diseases such as oophoritis, gastritis, thyroiditis, and orchitis were induced in female or male nude (nu/nu) mice by the transfer of nu/+spleen cells from which particular Lyt T cell subset(s) had been removed: nu/+spleen cells treated with anti-Lyt-1 plus complement (C) caused disease in recipient nude mice; anti-Lyt-2 plus C-treated spleen cells, in contrast, did not. The cells responsible for disease induction are believed to be Thy-1+, Lyt-1-, 2,3- (Thy-1, Lyt-1, 2,3), since spleen cells treated with mixed antisera, including anti-Lyt-1 and anti-Lyt-2, plus C, could induce the disease with almost the same incidence as anti-Lyt-1 plus C-treated cells (oophoritis 50%, gastritis 25%, thyroiditis 10-20%, and orchitis 40%). Cells treated with mixed antisera of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, could not induce autoimmune disease. Each induced autoimmune disease could be adoptively transferred to other nude mice via spleen cells, with resulting histological lesion of corresponding organs and development of specific circulating autoantibodies. Since anti-Thy-1 plus C treatment of donor spleen cells abrogated the capacity to transfer the disease, we conclude that T cells are required as effector cells, and that these may develop from Lyt-1-, 2,3- cells. Lyt-1+, 2,3- cells were demonstrated to have suppressive activity upon the development of the diseases; induction of autoimmunity was completely inhibited by the cotransfer of Lyt-1+, 2,3- cells with Lyt-1-, 2,3- cells. When anti-Lyt-2 plus C-treated cells (i.e., Lyt-1+, 2,3- and Lyt-1-, 2,3- cells) were mixed with anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (i.e., Lyt-1-, 2,3- cells) in various ratios, then transferred to nude mice, the development of each autoimmune disease was clearly inhibited, even by small doses of Lyt-1+, 2,3- cells. The autoimmune disease we were able to induce was quite similar to human organ-specific autoimmune disease in terms of the spectrum of organs involved, histopathological features, and the development of autoantibodies to corresponding organ components (oocytes, parietal cells, thyroid colloid, including thyroglobulin, and sperm).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.
Sakaguchi S, Takahashi T, Nishizuka Y. Sakaguchi S, et al. J Exp Med. 1982 Dec 1;156(6):1565-76. doi: 10.1084/jem.156.6.1565. J Exp Med. 1982. PMID: 6983557 Free PMC article. - Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
Sugihara S, Izumi Y, Yoshioka T, Yagi H, Tsujimura T, Tarutani O, Kohno Y, Murakami S, Hamaoka T, Fujiwara H. Sugihara S, et al. J Immunol. 1988 Jul 1;141(1):105-13. J Immunol. 1988. PMID: 2967864 - A novel experimental system of organ-localized autoimmune diseases in the mouse.
Nishizuka Y. Nishizuka Y. Acta Pathol Jpn. 1982;32 Suppl 1:211-22. Acta Pathol Jpn. 1982. PMID: 6764999 Review. - Mechanisms of autoimmune disease in the testis and ovary.
Tung KS, Teuscher C. Tung KS, et al. Hum Reprod Update. 1995 Jan;1(1):35-50. doi: 10.1093/humupd/1.1.35. Hum Reprod Update. 1995. PMID: 9080205 Review.
Cited by
- Non-invasive detection of regulatory T cells with Raman spectroscopy.
Pavillon N, Lim EL, Tanaka A, Hori S, Sakaguchi S, Smith NI. Pavillon N, et al. Sci Rep. 2024 Jun 18;14(1):14025. doi: 10.1038/s41598-024-64536-0. Sci Rep. 2024. PMID: 38890425 Free PMC article. - Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy.
Singh V, Nandi S, Ghosh A, Adhikary S, Mukherjee S, Roy S, Das C. Singh V, et al. Cancer Metastasis Rev. 2024 Mar;43(1):175-195. doi: 10.1007/s10555-024-10167-w. Epub 2024 Jan 18. Cancer Metastasis Rev. 2024. PMID: 38233727 Review. - Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells.
Wang X, Geng S, Meng J, Kang N, Liu X, Xu Y, Lyu H, Xu Y, Xu X, Song X, Zhang B, Wang X, Nuerbulati N, Zhang Z, Zhai D, Mao X, Sun R, Wang X, Wang R, Guo J, Chen SRW, Zhou X, Xia T, Qi H, Hu X, Shi Y. Wang X, et al. J Clin Invest. 2023 Dec 15;133(24):e163470. doi: 10.1172/JCI163470. J Clin Invest. 2023. PMID: 38099494 Free PMC article. - The role of transcription factors in shaping regulatory T cell identity.
Trujillo-Ochoa JL, Kazemian M, Afzali B. Trujillo-Ochoa JL, et al. Nat Rev Immunol. 2023 Dec;23(12):842-856. doi: 10.1038/s41577-023-00893-7. Epub 2023 Jun 19. Nat Rev Immunol. 2023. PMID: 37336954 Free PMC article. Review. - Intricacies of TGF-β signaling in Treg and Th17 cell biology.
Wang J, Zhao X, Wan YY. Wang J, et al. Cell Mol Immunol. 2023 Sep;20(9):1002-1022. doi: 10.1038/s41423-023-01036-7. Epub 2023 May 23. Cell Mol Immunol. 2023. PMID: 37217798 Free PMC article. Review.
References
- J Exp Med. 1975 Apr 1;141(4):904-17 - PubMed
- Immunogenetics. 1981;14(1-2):15-27 - PubMed
- Transplant Rev. 1976;31:23-43 - PubMed
- Clin Exp Immunol. 1976 Jul;25(1):6-16 - PubMed
- J Immunol. 1977 Feb;118(2):485-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous